Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension

Completed

Conditions studied: Hypertension, Pulmonary

In brief

The TOPP-2 registry is an international, non-interventional, prospective registry including children and adolescents newly diagnosed with pulmonary hypertension (PH) to gain further insights in the disease course and long-term outcome of PH in childhood. Patients will undergo clinical assessments and receive standard medical care, as determined by treating physicians in their daily clinical practice. The TOPP-2 registry is specifically designed to capture the variables that have been proposed as treatment goals in PePH and the reasons for changes in treatment strategy. The TOPP-2 registry uses the new clinical classification of PH as outlined at the 5th World Symposium for Pulmonary Hypertension (WSPH) in Nice 2013 and includes new characterizations for children with PH. The registry is planned and implemented under the scientific leadership of the Association for Pediatric Pulmonary Hypertension (PePH), independently from the financial sponsors. All enrolled patients will have a follow-up period of 18 months.

Key facts

Study ID

NCT02610660

Run by

Association for Pediatric Pulmonary Hypertension

People needed

388

Starts

2015-08-01

Expected to finish

2022-12-31

Last updated by the study team

2023-04-13

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must be an incident patient, i.e.newly diagnosed with PH
• Age at time of diagnosis is at least 3 months and less than 18 years
• Patients must present with PH belonging to one of the following categories
• Group 1 according to updated Nice clinical classification
• Group 3 according to updated Nice clinical classification
• Group 4 according to updated Nice clinical classification
• Group 5 according to updated Nice clinical classification
• PH confirmed by heart catheterisation (HC)
• At HC, the patient must present with mean pulmonary arterial pressure (PAP) of at least 25 mmHg at rest, a pulmonary vascular resistance index (PVRi) equal to or below 3 Wood units*m\^2 and mean pulmonary arterial wedge pressure (PAWP) below or equal to 15 mmHg
• In case of congenital heart disease (CHD) patients who had undergone palliative procedure or repair to close systemic to pulmonary shunt, the diagnosis of PH must have been confirmed by HC at least 6 months after surgery/palliative procedure took place
• For patients with PAH-CHD open shunt, only those considered not operable due to advanced pulmonary vascular disease are eligible
• Patients to be included into the registry, and/or their legal guardians, must give informed consent. Where applicable patients will be asked for their written assent
• Participating sites must agree to adhere to the recommendations of the WSPH 2015 Nice, Pediatric Taskforce.

You may not qualify if…

• Patients belonging to Group 2 according to updated Nice clinical classification

Where it is running

• Stanford Children's Hospital — Palo Alto, California, United States
• University of Colorado Denver School of Medicine, Children's Hospital Colorado — Aurora, Colorado, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• Emory University — Atlanta, Georgia, United States
• Boston Children's Hospital — Boston, Massachusetts, United States
• St Louis Children's Hospital — St Louis, Missouri, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Columbia University Medical Center — New York, New York, United States
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
• Vanderbilt University Children's Hospital — Nashville, Tennessee, United States
• Texas Children's Hospital — Houston, Texas, United States
• Primary Children's Hospital — Salt Lake City, Utah, United States
• Seattle Children's Hospital — Seattle, Washington, United States
• Royal Children's Hospital — Melbourne, Australia
• University of São Paulo — São Paulo, Brazil
• The Hospital for Sick Children — Toronto, Ontario, Canada
• Fu Wai Hospital — Beijing, China
• Hospital Pediátrico La Misericordia — Bogotá, Colombia
• Université Paris Descartes — Paris, France
• University Children's Hospital Ulm — Ulm, Germany
• Institute of Cardiology — Budapest, Hungary
• Hadassah, Hebrew University Medical Center — Jerusalem, Israel
• University of Padova — Padova, Italy
• Toho Universit Omori Medical Center — Tokyo, Japan
• Keio University — Tokyo, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.